首页> 外文期刊>Pharmacology & Pharmacy >Identification, Characterization and Evaluation of Crystal Forms of Quinine Sulphate
【24h】

Identification, Characterization and Evaluation of Crystal Forms of Quinine Sulphate

机译:奎宁硫酸盐晶体形式的鉴定,表征和评价

获取原文
           

摘要

Crystal engineering concept has been utilized to modify the physico-chemical parameters of a naturally occurring alkaloid, quinine sulphate, by exploring its H-bond interactions to generate different forms. Quinine sulphate is found to exist in four different crystal forms. The Forms I and II depict endo/exo events suggesting conversion of metastable low melting forms to higher melting and stable form indicated by sharp melting endotherms. The low melting form IL is found to be monotropically related to high melting Form IH while low melting Form IIL is enantiotropically related to high melting Form IIH. The Form III and IV showed broad endotherms accompanied by mass loss in TGA prior to melting indicating the existence of solvatomorphism. The solvent molecules are tightly bound in the crystal lattice of the drug molecules which is shown by high values of the binding energies of the solvents in these two forms. The enthalpy of solution was found to be endothermic for all the forms which followed the order: Form O > Form II > Form III > Form I > Form IV and is further related to the lattice energy suggesting Form II to be least crystalline. The solubility for Form II was found to be highest with maximum release rate in dissolution studies. The effectiveness of new polymorphic forms was confirmed by performing in vivo antimalarial activity against P. berghei infection. The studies have shown an increase in antimalarial activity of Form IV concluding a successful development of new polymorphic form.
机译:晶体工程概念已被用来通过研究其氢键相互作用产生不同形式来改变天然生物碱奎宁硫酸盐的物理化学参数。发现硫酸奎宁以四种不同的晶体形式存在。形式I和II描述了内/外事件,表明亚稳的低熔点形式转化为高熔点和稳定形式,由急剧的熔化吸热表示。发现低熔点形式IL与高熔点形式IH单向相关,而低熔点形式IIL与高熔点形式IIH对映相关。晶型III和IV表现出较宽的吸热,并伴随着熔化前TGA的质量损失,表明存在溶同晶。溶剂分子紧密结合在药物分子的晶格中,这通过这两种形式的溶剂的结合能的高值表示。发现溶液的焓对于遵循以下顺序的所有形式是吸热的:形式O>形式II>形式III>形式I>形式IV,并且进一步与晶格能量有关,表明形式II为最低结晶度。在溶解研究中,发现II型的溶解度最高,释放速率最大。通过对伯氏疟原虫感染进行体内抗疟活性证实了新的多晶型形式的有效性。研究表明形式IV的抗疟活性增加,从而成功开发了新的多晶型形式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号